Project Grant SB1HD118921
Award Date
4/10/25
Completion Date
3/31/27
Dollars Obligated
$2M
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The National Institute of Child Health and Human Development (NICHD) awarded a $759,944 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Nextgenjane Inc., a women's health startup, to commercialize a non-invasive diagnostic test for endometriosis. The funding will support validation studies of Nextgenjane's high-performance genomic assay for detecting endometriosis in the intended-use population of infertility patients. This diagnostic could enable...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop new non-hormonal and non-opioid therapies for treating endometriosis-associated pain. The $254,610 grant funds research to: 1) identify inflammatory mediators and signaling pathways in macrophages activated by the neurotransmitter CGRP, which contributes to lesion formation and endometrial cell growth; 2)...
The National Institute of Child Health and Human Development (NICHD) awarded a $384,418 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to Serentrix LLC, a biotech company, to validate the efficacy of their lead compound SER-014, a TRPV1 receptor antagonist, for treating endometriosis-associated pain. The project aims to measure the efficacy of SER-014 in a validated mouse model of endometriosis and confirm the compound's mechanism of action...
This Project Grant award, funded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to identify the underlying mechanisms of pain in endometriosis. The $233,250 award to The Washington University in St. Louis will support a 2-year study to examine both central and peripheral factors contributing to endometriosis pain, including inhibitory pain modulation, estrogen levels, and...
The University of Illinois was awarded a $643,049 Project Grant under the National Institutes of Health's Child Health and Human Development Extramural Research program (CFDA 93.865) to develop a physiomimetic model of the endometrioma lesion microenvironment. The objective is to investigate processes responsible for the initiation and invasion of endometriosis lesions, an estrogen-dependent disease affecting 10% of menstruating individuals. The research aims to uncover multicellular...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $343,510 in funding to Theranova LLC, a veteran-owned medical device research and development company in San Francisco, CA. The grant supports the development and pilot evaluation of the SOLESTIM neuromodulation system, a portable, non-invasive device designed to treat dysmenorrhea (painful menstrual...
This federal Project Grant award for $131,085 was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research to gain a better understanding of the contribution of uterine natural killer (UNK) cells to the pathobiology of endometriosis, a debilitating chronic disease affecting 10% of reproductive-age women worldwide. The proposed work aims to characterize the...
This Project Grant award, funded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to characterize the epigenetic and genetic mechanisms underlying different stages of endometriosis. The award of $731,893 to the University of Texas Health Science Center at San Antonio will support large-scale single-cell epigenomic profiling to understand disrupted gene regulation in low and high-stage...
The National Institute of Child Health and Human Development (NICHD) awarded a Project Grant of $300,792.00 to Gynion, LLC on September 5, 2023 under the Child Health and Human Development Extramural Research program (CFDA 93.865). The funding will support the development and testing of MENORRX, a drug-device combination product intended to provide a non-invasive, cost-effective treatment for heavy menstrual bleeding (HMB). The proposed work aims to demonstrate the viability of the Yorkshire pig...
This Project Grant award from the National Institutes of Health's (NIH) Trans-NIH Research Support program (CFDA 93.310) provides $794,894 to The University of Texas Health Science Center at San Antonio (UTHSCSA) to conduct research on hormonal influences on inflammation in endometriosis. The overarching goal is to characterize key immune pathways that interact with hormonal responses in endometriosis through large-scale genetic studies and single-cell systems biology analyses. A sub-award of...